174 related articles for article (PubMed ID: 33651314)
21. Glycoxidative modification of AA amyloid deposits in renal tissue.
Uesugi N; Sakata N; Nagai R; Jono T; Horiuchi S; Takebayashi S
Nephrol Dial Transplant; 2000 Mar; 15(3):355-65. PubMed ID: 10692521
[TBL] [Abstract][Full Text] [Related]
22. Association between clinical characteristics and AL amyloid deposition in the kidney.
Itabashi M; Takei T; Tsukada M; Sugiura H; Uchida K; Tsuchiya K; Honda K; Nitta K
Heart Vessels; 2010 Nov; 25(6):543-8. PubMed ID: 20922533
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for renal amyloidosis: a clinicopathological study using cluster analysis.
Sasatomi Y; Sato H; Chiba Y; Abe Y; Takeda S; Ogahara S; Murata T; Kaneoka H; Takebayashi S; Iwasaki H; Saito T
Intern Med; 2007; 46(5):213-9. PubMed ID: 17329915
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic value of subcutaneous tissue biopsy in patients with cardiac amyloidosis.
Takashio S; Izumiya Y; Jinnin M; Yamamuro M; Kojima S; Ihn H; Ogawa H
Am J Cardiol; 2012 Nov; 110(10):1507-11. PubMed ID: 22863178
[TBL] [Abstract][Full Text] [Related]
25. The long-term prognosis of AA and AL renal amyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis.
Bohle A; Wehrmann M; Eissele R; von Gise H; Mackensen-Haen S; Müller C
Pathol Res Pract; 1993 Apr; 189(3):316-31. PubMed ID: 8332574
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of histopathological scoring and grading in patients with renal AA amyloidosis.
Ozdemir A; Yılmaz M; Ozagari AA; Kocak SY
Int Urol Nephrol; 2022 Oct; 54(10):2591-2597. PubMed ID: 35275358
[TBL] [Abstract][Full Text] [Related]
27. The clinicopathological spectrum of renal amyloidosis.
Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
[TBL] [Abstract][Full Text] [Related]
28. Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis.
Rezk T; Salota R; Gan JJ; Lachmann HJ; Fontana M; Siew K; Martinez-Naharro A; Guillotte C; Bass P; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Dockrell M; Foard D; Lane T; Wechalekar AD; Hawkins PN; Walsh SB; Gillmore JD
Br J Haematol; 2021 Sep; 194(6):1016-1023. PubMed ID: 34374069
[TBL] [Abstract][Full Text] [Related]
29. Persistence of renal function in a patient diagnosed with concurrent amyloid amyloidosis and immunoglobulin light chain amyloidosis.
Watanabe R; Ito K; Yasuno T; Abe Y; Hamauchi A; Yasunaga T; Sasatomi Y; Hisano S; Saito T; Nakashima H
Nihon Jinzo Gakkai Shi; 2016; 58(5):668-74. PubMed ID: 30375826
[TBL] [Abstract][Full Text] [Related]
30. Tubular basement membrane amyloid deposition: is it an indicator of renal progression in light chain amyloidosis?
Markóth C; Bidiga L; Váróczy L; File I; Balla J; Mátyus J
Ren Fail; 2023 Dec; 45(1):2203776. PubMed ID: 37125610
[TBL] [Abstract][Full Text] [Related]
31. Association between clinical parameters and amyloid-positive area in gastroduodenal biopsy in reactive amyloidosis associated with rheumatoid arthritis.
Kuroda T; Tanabe N; Kobayashi D; Sato H; Wada Y; Murakami S; Nakano M; Narita I
Rheumatol Int; 2012 Apr; 32(4):933-9. PubMed ID: 21240500
[TBL] [Abstract][Full Text] [Related]
32. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of renal amyloidosis: a clinicopathological study using cluster analysis.
Sasatomi Y; Kiyoshi Y; Uesugi N; Hisano S; Takebayashi S
Nephron; 2001 Jan; 87(1):42-9. PubMed ID: 11174025
[TBL] [Abstract][Full Text] [Related]
34. Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation.
Fenoglio R; Baldovino S; Ferro M; Sciascia S; Rabajoli G; Quattrocchio G; Beltrame G; Naretto C; Rossi D; Alpa M; Barreca A; Papotti MG; Roccatello D
J Nephrol; 2021 Feb; 34(1):231-240. PubMed ID: 32472525
[TBL] [Abstract][Full Text] [Related]
35. Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor.
Rezk T; Lachmann HJ; Fontana M; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Foard D; Lane T; Youngstein T; Wechalekar AD; Bass P; Hawkins PN; Gillmore JD
Kidney Int; 2017 Dec; 92(6):1476-1483. PubMed ID: 28729034
[TBL] [Abstract][Full Text] [Related]
36. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosis.
Osawa Y; Kawamura K; Kondo D; Imai N; Ueno M; Nishi S; Iino N; Okada M; Suzuki Y; Hoshino S; Yamazaki H; Kishimoto H; Shimada H; Yamagishi T; Ishiyama T; Narita I; Gejyo F
Clin Exp Nephrol; 2004 Jun; 8(2):127-33. PubMed ID: 15235929
[TBL] [Abstract][Full Text] [Related]
37. Light chain renal amyloidosis with prominent giant cells.
Troxell ML; Griffiths R; Schnadig I; Houghton DC
Am J Kidney Dis; 2013 Dec; 62(6):1193-7. PubMed ID: 23891357
[TBL] [Abstract][Full Text] [Related]
38. Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis.
Suzuki T; Kusumoto S; Yamashita T; Masuda A; Kinoshita S; Yoshida T; Takami-Mori F; Takino H; Ito A; Ri M; Ishida T; Komatsu H; Ueda M; Ando Y; Inagaki H; Iida S
Ann Hematol; 2016 Jan; 95(2):279-85. PubMed ID: 26555284
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes and survival in AA amyloidosis patients.
Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M
Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691
[TBL] [Abstract][Full Text] [Related]
40. Renal amyloidosis: an update on diagnosis and pathogenesis.
Gupta N; Kaur H; Wajid S
Protoplasma; 2020 Sep; 257(5):1259-1276. PubMed ID: 32447467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
